authors.affiliation: 1 Klinik für Infektiologie und Spitalhygiene, Universitätsspital Basel.
authors.forename: Michael
authors.initials: M
authors.lastname: Osthoff
authors.affiliation: 1 Klinik für Infektiologie und Spitalhygiene, Universitätsspital Basel.
authors.forename: Veronika
authors.initials: V
authors.lastname: Bättig
authors.affiliation: 1 Klinik für Infektiologie und Spitalhygiene, Universitätsspital Basel.
authors.forename: Nina
authors.initials: N
authors.lastname: Khanna
mesh_terms: D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods; D019317:Evidence-Based Medicine; D005767:Gastrointestinal Diseases / Q000139:chemically induced* / Q000517:prevention & control*; D006801:Humans; D009181:Mycoses / Q000188:drug therapy*; D009570:Nitriles / Q000008:administration & dosage* / Q000009:adverse effects*; D011725:Pyridines / Q000008:administration & dosage* / Q000009:adverse effects*; D016896:Treatment Outcome; D014230:Triazoles / Q000008:administration & dosage* / Q000009:adverse effects*
chemical_list: D000935:Antifungal Agents; D009570:Nitriles; D011725:Pyridines; D014230:Triazoles; C508735:isavuconazole